1. Home
  2. IPHA vs QSG Comparison

IPHA vs QSG Comparison

Compare IPHA & QSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IPHA
  • QSG
  • Stock Information
  • Founded
  • IPHA 1999
  • QSG 2019
  • Country
  • IPHA France
  • QSG China
  • Employees
  • IPHA N/A
  • QSG N/A
  • Industry
  • IPHA Biotechnology: Pharmaceutical Preparations
  • QSG Other Consumer Services
  • Sector
  • IPHA Health Care
  • QSG Real Estate
  • Exchange
  • IPHA Nasdaq
  • QSG Nasdaq
  • Market Cap
  • IPHA 160.1M
  • QSG 140.0M
  • IPO Year
  • IPHA 2019
  • QSG 2023
  • Fundamental
  • Price
  • IPHA $2.34
  • QSG $6.91
  • Analyst Decision
  • IPHA Strong Buy
  • QSG
  • Analyst Count
  • IPHA 1
  • QSG 0
  • Target Price
  • IPHA $11.00
  • QSG N/A
  • AVG Volume (30 Days)
  • IPHA 31.8K
  • QSG 408.0K
  • Earning Date
  • IPHA 03-27-2025
  • QSG 06-05-2025
  • Dividend Yield
  • IPHA N/A
  • QSG 2.95%
  • EPS Growth
  • IPHA N/A
  • QSG 101.59
  • EPS
  • IPHA N/A
  • QSG 1.04
  • Revenue
  • IPHA $20,831,349.00
  • QSG $477,141,565.00
  • Revenue This Year
  • IPHA $209.83
  • QSG N/A
  • Revenue Next Year
  • IPHA $83.96
  • QSG $6.09
  • P/E Ratio
  • IPHA N/A
  • QSG $6.32
  • Revenue Growth
  • IPHA N/A
  • QSG N/A
  • 52 Week Low
  • IPHA $1.29
  • QSG $1.47
  • 52 Week High
  • IPHA $3.51
  • QSG $7.96
  • Technical
  • Relative Strength Index (RSI)
  • IPHA 67.63
  • QSG 68.49
  • Support Level
  • IPHA $2.22
  • QSG $6.26
  • Resistance Level
  • IPHA $2.45
  • QSG $7.15
  • Average True Range (ATR)
  • IPHA 0.14
  • QSG 0.61
  • MACD
  • IPHA 0.03
  • QSG 0.10
  • Stochastic Oscillator
  • IPHA 82.52
  • QSG 92.10

About IPHA Innate Pharma S.A. ADS

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.

About QSG QuantaSing Group Limited

QuantaSing Group Ltd is a learning service provider in China's adult learning market for personal interest courses. It offers easy-to-understand, affordable, and accessible online courses to adult learners under various brands, including QiNiu, Kelly, and QianChi among others empowering them to pursue personal development. The company offers courses for various domains such as financial literacy, skill upgrading, recreation, and leisure which are offered in live large-class dual-instructor mode, online community-based training camp mode, and in live lecture, one-on-one tutoring mode. Its segments are; Learning service and others which derives key revenue, and Consumer business. Geographically, the company generates all of its revenue from the People's Republic of China.

Share on Social Networks: